ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Large Growth in Short Interest

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) saw a significant growth in short interest in November. As of November 15th, there was short interest totalling 8,600 shares, a growth of 32.3% from the October 31st total of 6,500 shares. Based on an average trading volume of 14,800 shares, the short-interest ratio is presently 0.6 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. Jane Street Group LLC bought a new stake in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 10,520 shares of the company’s stock, valued at approximately $158,000. Jane Street Group LLC owned approximately 4.78% of ProShares UltraShort Nasdaq Biotechnology as of its most recent filing with the Securities and Exchange Commission.

ProShares UltraShort Nasdaq Biotechnology Price Performance

Shares of NASDAQ:BIS opened at $15.83 on Friday. The business has a 50-day simple moving average of $15.58 and a two-hundred day simple moving average of $15.79. ProShares UltraShort Nasdaq Biotechnology has a fifty-two week low of $14.05 and a fifty-two week high of $23.42.

ProShares UltraShort Nasdaq Biotechnology Cuts Dividend

The firm also recently declared a dividend, which was paid on Wednesday, October 2nd. Stockholders of record on Wednesday, September 25th were given a dividend of $0.1518 per share. The ex-dividend date was Wednesday, September 25th.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.